All reagents are required to perform blood testing at medical treatment facilities

Ended Awarded Last action

Contract number
HT009026FG0330032
Awardee
Awarding agency
Obligated
$25,000

Award facts

Contract value 100% obligated
$24,999.99 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6640 Laboratory Equipment And Supplies
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
North Chicago, IL 60064, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The Defense Health Agency issued a BPA call to Abbott Laboratories Inc. on March 13, 2026, for blood testing reagents with a ceiling value of $24,999.99. The call delivers all reagents required to perform blood testing at military medical treatment facilities. Place of performance is North Chicago, Illinois. The call is firm fixed price with an ultimate completion date of September 30, 2026 and was issued under full and open competition with no set-aside.

Quick answers

Who was awarded contract HT009026FG0330032?

HT009026FG0330032 was awarded to Abbott Laboratories Inc. by Defense Health Agency (Department of Defense) on March 13, 2026.

How much is contract HT009026FG0330032 worth?

The government has obligated $25,000 on HT009026FG0330032.

Is contract HT009026FG0330032 an order under another contract?

Yes. HT009026FG0330032 is a BPA call under FA301624A0044, a blanket purchase agreement.

Was contract HT009026FG0330032 competed?

The extent of competition for HT009026FG0330032 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login